Donges B, Haupt LM, Lea RA, Chan RC, Shum DH, Griffiths LR. Role of the apolipoprotein E and catechol-O-methyltransferase genes in prospective and retrospective memory traits. Gene. 2012;506:135–40.
Article
CAS
PubMed
Google Scholar
Hatters DM, Peters-Libeu CA, Weisgraber KH. Apolipoprotein E structure: insights into function. Trends Biochem Sci. 2006;31:445–54.
Article
CAS
PubMed
Google Scholar
Mahley RW, Innerarity TL, Rall SC Jr, Weisgraber KH. Plasma lipoproteins: apolipoprotein structure and function. J Lipid Res. 1984;25:1277–94.
Article
CAS
PubMed
Google Scholar
Hanh NT, Nhung BT, Dao DT, Tuyet LT, Hop LT, Binh TQ, et al. Association of apolipoprotein E polymorphism with plasma lipid disorders, independent of obesity-related traits in Vietnamese children. Lipids Health Dis. 2016;15:176.
Article
PubMed
PubMed Central
CAS
Google Scholar
Zhong Z, Wu H, Wu H, Zhao P. Analysis of apolipoprotein E genetic polymorphism in a large ethnic Hakka population in southern China. Genet Mol Biol. 2018;41:742–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Mahley RW, Rall SC Jr. Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet. 2000;1:507–37.
Article
CAS
PubMed
Google Scholar
Hoyert DL, Xu J. Deaths: preliminary data for 2011. Natl Vital Stat Rep. 2012;61:1–51.
PubMed
Google Scholar
Daar AS, Singer PA, Persad DL, Pramming SK, Matthews DR, Beaglehole R, et al. Grand challenges in chronic non-communicable diseases. Nature. 2007;450:494–6.
Article
CAS
PubMed
Google Scholar
Mikton CR, Butchart A, Dahlberg LL, Krug EG. Global status report on violence prevention 2014. Am J Prev Med. 2016;50:652–9.
Article
PubMed
Google Scholar
Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420:860–7.
Article
CAS
PubMed
PubMed Central
Google Scholar
Libby P. Inflammation in atherosclerosis. Nature. 2002;420:868–74.
Article
CAS
PubMed
Google Scholar
Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet. 2001;357:539–45.
Article
CAS
PubMed
Google Scholar
Kundu JK, Surh YJ. Emerging avenues linking inflammation and cancer. Free Radic Biol Med. 2012;52:2013–37.
Article
CAS
PubMed
Google Scholar
Hussain SP, Harris CC. Inflammation and cancer: an ancient link with novel potentials. Int J Cancer. 2007;121:2373–80.
Article
CAS
PubMed
Google Scholar
Koene RJ, Prizment AE, Blaes A, Konety SH. Shared risk factors in cardiovascular disease and cancer. Circulation. 2016;133:1104–14.
Article
PubMed
PubMed Central
Google Scholar
Muntoni S, Atzori L, Mereu R, Satta G, Macis MD, Congia M, et al. Serum lipoproteins and cancer. Nutr Metab Cardiovasc Dis. 2009;19:218–25.
Article
CAS
PubMed
Google Scholar
Tornberg SA, Holm LE, Carstensen JM, Eklund GA. Risks of cancer of the colon and rectum in relation to serum cholesterol and beta-lipoprotein. N Engl J Med. 1986;315:1629–33.
Article
CAS
PubMed
Google Scholar
Kalita S, Khandelwal S, Madan J, Pandya H, Sesikeran B, Krishnaswamy K. Almonds and cardiovascular health: a review. Nutrients. 2018;10:468.
Article
PubMed Central
CAS
Google Scholar
Pires A, Sena C, Seica R. Dyslipidemia and cardiovascular changes in children. Curr Opin Cardiol. 2016;31:95–100.
Article
PubMed
Google Scholar
Eichner JE, Dunn ST, Perveen G, Thompson DM, Stewart KE, Stroehla BC. Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review. Am J Epidemiol. 2002;155:487–95.
Article
PubMed
Google Scholar
Mendes-Lana A, Pena GG, Freitas SN, Lima AA, Nicolato RL, Nascimento-Neto RM, et al. Apolipoprotein E polymorphism in Brazilian dyslipidemic individuals: Ouro Preto study. Braz J Med Biol Res. 2007;40:49–56.
Article
CAS
PubMed
Google Scholar
de Boer RA, Hulot JS, Tocchetti CG, Aboumsallem JP, Ameri P, Anker SD, et al. Common mechanistic pathways in cancer and heart failure. A scientific roadmap on behalf of the Translational Research Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur J Heart Fail. 2020;22:2272–89.
Article
PubMed
Google Scholar
Bracun V, Suthahar N, Shi C, de Wit S, Meijers WC, Klip IT, et al. Established tumour biomarkers predict cardiovascular events and mortality in the general population. Front Cardiovasc Med. 2021;8:753885.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ram P, Tiu A, Lo KB, Parikh K, Shah M. Trends in the prevalence of malignancy among patients admitted with acute heart failure and associated outcomes: a nationwide population-based study. Heart Fail Rev. 2019;24:989–95.
Article
CAS
PubMed
Google Scholar
Sturgeon KM, Deng L, Bluethmann SM, Zhou S, Trifiletti DM, Jiang C, et al. A population-based study of cardiovascular disease mortality risk in US cancer patients. Eur Heart J. 2019;40:3889–97.
Article
PubMed
PubMed Central
Google Scholar
Bahri R, Esteban E, Moral P, Hassine M, Ben Hamda K, Chaabani H. Apolipoprotein gene polymorphisms and plasma levels in healthy Tunisians and patients with coronary artery disease. Lipids Health Dis. 2008;7:46.
Article
PubMed
PubMed Central
CAS
Google Scholar
Jervies JL, King SP, Suphioglu C. Apolipoprotein E4 as a novel treatment target for Alzheimer’s disease. Cell Physiol Biochem. 2021;55:773–83.
Article
PubMed
CAS
Google Scholar
Chaudhary R, Likidlilid A, Peerapatdit T, Tresukosol D, Srisuma S, Ratanamaneechat S, et al. Apolipoprotein E gene polymorphism: effects on plasma lipids and risk of type 2 diabetes and coronary artery disease. Cardiovasc Diabetol. 2012;11:36.
Article
CAS
PubMed
PubMed Central
Google Scholar
Mahley RW. Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders. J Mol Med (Berl). 2016;94:739–46.
Article
CAS
PubMed
PubMed Central
Google Scholar
Eichner JE, Kuller LH, Orchard TJ, Grandits GA, McCallum LM, Ferrell RE, et al. Relation of apolipoprotein E phenotype to myocardial infarction and mortality from coronary artery disease. Am J Cardiol. 1993;71:160–5.
Article
CAS
PubMed
Google Scholar
Guan J, Zhao HL, Baum L, Sui Y, He L, Wong H, et al. Apolipoprotein E polymorphism and expression in type 2 diabetic patients with nephropathy: clinicopathological correlation. Nephrol Dial Transplant. 2009;24:1889–95.
Article
CAS
PubMed
Google Scholar
Chang NW, Chen DR, Wu CT, Aouizerat BE, Chen FN, Hung SJ, et al. Influences of apolipoprotein E polymorphism on the risk for breast cancer and HER2/neu status in Taiwan. Breast Cancer Res Treat. 2005;90:257–61.
Article
CAS
PubMed
Google Scholar
De Feo E, Rowell J, Cadoni G, Nicolotti N, Arzani D, Giorgio A, et al. A case-control study on the effect of apoliprotein E genotype on head and neck cancer risk. Cancer Epidemiol Biomarkers Prev. 2010;19:2839–46.
Article
PubMed
Google Scholar
De Feo E, Simone B, Persiani R, Cananzi F, Biondi A, Arzani D, et al. A case-control study on the effect of apolipoprotein E genotypes on gastric cancer risk and progression. BMC Cancer. 2012;12:494.
Article
PubMed
PubMed Central
CAS
Google Scholar
Ivanova TI, Krikunova LI, Ryabchenko NI, Mkrtchyan LS, Khorokhorina VA, Salnikova LE. Association of the apolipoprotein E 2 allele with concurrent occurrence of endometrial hyperplasia and endometrial carcinoma. Oxid Med Cell Longev. 2015;2015:593658.
Article
PubMed
PubMed Central
Google Scholar
Sidaraite A, Vilkeviciute A, Glebauskiene B, Kriauciuniene L, Zaliuniene D, Liutkeviciene R. Association of ApoE haplotype with clinical evidence of pituitary adenoma. Gene. 2019;706:154–61.
Article
CAS
PubMed
Google Scholar
Slattery ML, Sweeney C, Murtaugh M, Ma KN, Potter JD, Levin TR, et al. Associations between apoE genotype and colon and rectal cancer. Carcinogenesis. 2005;26:1422–9.
Article
CAS
PubMed
Google Scholar
Souza DR, Nakazone MA, Pinhel MA, Alvares RM, Monaco AC, Pinheiro A, et al. Association between apolipoprotein E genotype, serum lipids, and colorectal cancer in Brazilian individuals. Braz J Med Biol Res. 2009;42:397–403.
Article
CAS
PubMed
Google Scholar
Yencilek F, Yilmaz SG, Yildirim A, Gormus U, Altinkilic EM, Dalan AB, et al. Apolipoprotein E genotypes in patients with prostate cancer. Anticancer Res. 2016;36:707–11.
CAS
PubMed
Google Scholar
Moysich KB, Freudenheim JL, Baker JA, Ambrosone CB, Bowman ED, Schisterman EF, et al. Apolipoprotein E genetic polymorphism, serum lipoproteins, and breast cancer risk. Mol Carcinog. 2000;27:2–9.
Article
CAS
PubMed
Google Scholar
Cibeira GH, Giacomazzi J, Aguiar E, Schneider S, Ettrich B, CI DES, Camey S, Caleffi M, Weber B, Ashton-Prolla P, Moriguchi EH. Apolipoprotein E genetic polymorphism, serum lipoprotein levels and breast cancer risk: a case-control study. Mol. Clin Oncol. 2014;2:1009–15.
Google Scholar
Kang R, Li P, Wang T, Li X, Wei Z, Zhang Z, et al. Apolipoprotein E epsilon 2 allele and low serum cholesterol as risk factors for gastric cancer in a Chinese Han population. Sci Rep. 2016;6:19930.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kervinen K, Sodervik H, Makela J, Lehtola J, Niemi M, Kairaluoma MI, et al. Is the development of adenoma and carcinoma in proximal colon related to apolipoprotein E phenotype? Gastroenterology. 1996;110:1785–90.
Article
CAS
PubMed
Google Scholar
Shinomiya S, Sasaki J, Kiyohara C, Tsuji E, Inoue H, Marugame T, et al. Apolipoprotein E genotype, serum lipids, and colorectal adenomas in Japanese men. Cancer Lett. 2001;164:33–40.
Article
CAS
PubMed
Google Scholar
Watson MA, Gay L, Stebbings WS, Speakman CT, Bingham SA, Loktionov A. Apolipoprotein E gene polymorphism and colorectal cancer: gender-specific modulation of risk and prognosis. Clin Sci (Lond). 2003;104:537–45.
Article
CAS
PubMed
Google Scholar
Tian Y, Wang J, Ye Y, Sun L, Fan Y, Wang L, et al. Apolipoprotein E polymorphism and colorectal neoplasm: results from a meta-analysis. PLoS One. 2014;9:e102477.
Article
PubMed
PubMed Central
Google Scholar
Sing CF, Davignon J. Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation. Am J Hum Genet. 1985;37:268–85.
CAS
PubMed
PubMed Central
Google Scholar
Anand R, Prakash SS, Veeramanikandan R, Kirubakaran R. Association between apolipoprotein E genotype and cancer susceptibility: a meta-analysis. J Cancer Res Clin Oncol. 2014;140:1075–85.
Article
CAS
PubMed
Google Scholar
Kulminski AM, Culminskaya I, Ukraintseva SV, Arbeev KG, Arbeeva L, Wu D, et al. Trade-off in the effects of the apolipoprotein E polymorphism on the ages at onset of CVD and cancer influences human lifespan. Aging Cell. 2011;10:533–41.
Article
CAS
PubMed
Google Scholar
Marrero JA, Kulik LM, Sirlin CB, Zhu AX, Finn RS, Abecassis MM, et al. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases. Hepatology. 2018;68:723–50.
Article
PubMed
Google Scholar
El-Lebedy D, Raslan HM, Mohammed AM. Apolipoprotein E gene polymorphism and risk of type 2 diabetes and cardiovascular disease. Cardiovasc Diabetol. 2016;15:12.
Article
PubMed
PubMed Central
CAS
Google Scholar
Liu S, Liu J, Weng R, Gu X, Zhong Z. Apolipoprotein E gene polymorphism and the risk of cardiovascular disease and type 2 diabetes. BMC Cardiovasc Disord. 2019;19:213.
Article
PubMed
PubMed Central
CAS
Google Scholar
Liu S, Weng R, Gu X, Li L, Zhong Z. Association between apolipoprotein E gene polymorphism and nonalcoholic fatty liver disease in southern China: a case-control study. J Clin Lab Anal. 2021;35:e24061.
CAS
PubMed
PubMed Central
Google Scholar
Aboumsallem JP, Moslehi J, de Boer RA. Reverse cardio-oncology: cancer development in patients with cardiovascular disease. J Am Heart Assoc. 2020;9:e013754.
Article
PubMed
PubMed Central
Google Scholar
de Boer RA, Aboumsallem JP, Bracun V, Leedy D, Cheng R, Patel S, et al. A new classification of cardio-oncology syndromes. Cardiooncology. 2021;7:24.
PubMed
PubMed Central
Google Scholar
Banke A, Schou M, Videbaek L, Moller JE, Torp-Pedersen C, Gustafsson F, et al. Incidence of cancer in patients with chronic heart failure: a long-term follow-up study. Eur J Heart Fail. 2016;18:260–6.
Article
PubMed
Google Scholar
Conen D, Wong JA, Sandhu RK, Cook NR, Lee IM, Buring JE, et al. Risk of malignant cancer among women with new-onset atrial fibrillation. JAMA Cardiol. 2016;1:389–96.
Article
PubMed
PubMed Central
Google Scholar
Meijers WC, Maglione M, Bakker SJL, Oberhuber R, Kieneker LM, de Jong S, et al. Heart failure stimulates tumor growth by circulating factors. Circulation. 2018;138:678–91.
Article
CAS
PubMed
Google Scholar
Koelwyn GJ, Newman AAC, Afonso MS, van Solingen C, Corr EM, Brown EJ, et al. Myocardial infarction accelerates breast cancer via innate immune reprogramming. Nat Med. 2020;26:1452–8.
Article
PubMed
PubMed Central
CAS
Google Scholar
Mahley RW, Apolipoprotein E. cholesterol transport protein with expanding role in cell biology. Science. 1988;240:622–30.
Article
CAS
PubMed
Google Scholar
Seripa D, D'Onofrio G, Panza F, Cascavilla L, Masullo C, Pilotto A. The genetics of the human APOE polymorphism. Rejuvenation Res. 2011;14:491–500.
Article
CAS
PubMed
Google Scholar
Saadat M, Apolipoprotein E. (APOE) polymorphisms and susceptibility to breast cancer: a meta-analysis. Cancer Res Treat. 2012;44:121–6.
Article
PubMed
PubMed Central
Google Scholar
Chang SJ, Hou MF, Tsai SM, Kao JT, Wu SH, Hou LA, et al. Association between the apolipoprotein E genotypes and breast cancer patients in Taiwanese. Breast Cancer Res Treat. 2006;98:109–13.
Article
CAS
PubMed
Google Scholar
Yang C, Tian G, Mi J, Wei X, Li X, Li X, et al. Causal relevance of circulating high-density lipoprotein cholesterol with cancer: a Mendelian randomization meta-analysis. Sci Rep. 2015;5:9495.
Article
CAS
PubMed
PubMed Central
Google Scholar
Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129:S1–45.
Article
PubMed
Google Scholar